Stem cells in aging: Influence of ontogenic, genetic and environmental factors

Journal of Stem Cells

Volumn 1, Issue 2, 2006, Pages 125-147

  Yunis, Edmond J ^a,b   Zúñiga, Joaquin ^a,b,c   Koka, Prasad S ^d   Husain, Zaheed ^a,b   Romero, Viviana ^a   Stern, Joel N H ^a   Fridkis Hareli, Masha ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; DYSKERIN; GAMMA INTERFERON; GROWTH DIFFERENTIATION FACTOR 9; HEAT SHOCK PROTEIN 70; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; RAD50 PROTEIN; RETINOBLASTOMA PROTEIN; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AGING; CELL PROLIFERATION; DEATH; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENE INTERACTION; GENE MAPPING; GENE OVEREXPRESSION; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; LIFESPAN; LONGEVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROENVIRONMENT; MOLECULAR BIOLOGY; NONHUMAN; NUTRITION; ONTOGENY; ORGANOGENESIS; REVIEW; SENESCENCE; THYMUS;

ANIMALIA;

EID: 71449127381     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (163)

1. Lombard, DB; Chua, KF; Mostoslavsky, R; Franco, S; Gostissa, M; Alt, FW. DNA repair, genome stability, and aging. Cell, 2005, 120(4), 497-512.
2. Hathcock, KS; Chiang, YJ; Hodes, RJ. In vivo regulation of telomerase activity and telomere length. Immunol. Rev., 2005, 205, 104-113.
3. Colavitti, R; Finkel, T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life, 2005, 57(4-5), 277-81.
4. Jaenisch, R; Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet., 2003, 33 Suppl, 245-254.
5. Miura, T; Mattson, MP; Rao, MS. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell, 2004, 3, 333-343.
6. Yunis, EJ; Fernandez, G; Stutman, O. Susceptibility to involution of the thymus-dependent lymphoid system and autoimmunity. Am. J. Clin. Pathol., 1971, 56, 280-292.
7. Yunis, EJ; Ferndades, G; Good, RA. Aging and Involution of the Immunological apparatus. In The immunopathology of Lymphoreticular Neoplasms. Ed. JJ Twomey and Robert A. Good. Plenum Publishing Corporation, 1978, 53-80.
8. Teague, PO; Yunis, EJ; Rodey, G; Martinez, C; Good, RA. Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging and evolution of immunologic capacity. Lab. Invest., 1970, 22, 121-138.
9. Stutman, O; Yunis, EJ; Good, RA. Studies on thymus function. III duration of the thymic function. J. Exp. Med., 1972, 135, 339-356.
10. Hallgren, H; Buckley, CE; Gilbertsen, VA; Yunis, EJ. Lymphocyte PHA responsiveness, immunoglobulins and autoantibodies in aging humans. J. Immunol., 1973, 111, 1101-1107.
11. Good, RA; Yunis, EJ. Association of autoimmunity, immunodeficiency and aging in man, rabbits and mice. Fed. Proc., 1975, 33, 2040-2050.
12. Bodey, B; Bodey, B; Siegel, SE; Kaiser HE. Involution of the mammalian thymus, one of the leading regulators of aging. In Vivo. 1997, 11, 421-40.
13. Van Zant, G; de Haan, G. Genetic control of lifespan: studies from animal models. Expert. Rev. Mol. Med., 1999, 28, 1-12.
14. Smith, JR; Pereira-Smith, OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science, 1996, 273, 63-67.
15. Hayflick, L; Moorhead, PS. The serial cultivation of human diploid cell strains. Exp. Cell Res., 1961, 25, 585-621.
16. Thomson, JA; Itskovitz-Eldor, J; Shapiro, SS; Waknitz, MA; Swiergel, JJ; Marshall, VS; Jones, JM. Embrynic stem cell lines derived from human blastocysts. Science, 1998, 282, 1145-1147.
17. Kyono, T; Foster, SA; Koop, JI; McDougall, JK; Galloway, DA; Klingelhutz, AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to inmortalize human epithelial cells. Nature, 1998, 396, 84-88.
18. Szibor, M; Holtz, J. Mitochondrial ageing. Basic Res. Cardiol., 2003, 98, 210-218.
19. Bertram, MJ; Berube, NG; Hang-Swanson, X; Ran, Q; Leung, JK; Bryce, S; Spurgers, K; Bick, RJ; Baldini, A; Ning, Y; Clark, LJ; Parkinson, EK; Barret, JC; Smith, JR; Pereira-Smith, OM. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell Biol., 1999, 19, 1479-1485.
20. Tominaga, K; Olguin A; Smith JR; Pereira-Smith OM. Genetics of cellular senescence. Mech. Ageing Dev. 200, 123, 927-36.
21. Sandhu AK; Kaur GP; Reddy DG; Rane NS; Athwal RS. A gene on 6q 14-21 restores senescence to immortal ovarian tumor cells. Oncogene., 1996, 12, 247-52.
22. Oren, M; Rotter, V. Introduction p53-the first twenty years. Cell Mol. Life Sci., 1999, 55, 9-11.
23. Bargonetti, J; Manfredi, JJ. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol., 2002, 14, 86-91.
24. Di Leonardo, A; Linke, SP; Clarkin, K; Wahl, GM. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 1994, 8, 2540-2551.
25. Serrano, M; Lin, AW; McCurrach, ME; Beach, D; Lowe, SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 1997, 88, 593-602.
26. Lin, AW; Barradas, M; Stone, JC; van Aelst, L; Serrano, M; Lowe, SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 1998, 12, 3008-3019.
27. Sherr, CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev., 1998, 12, 2984-2991.
28. Dimri, GP; Itahana, K; Acosta, M; Campisi, J. Regulation of a secescence ckeckpoint response by the E2F1 transcription factor and p14 (ARF) tumor suppressor. Mol. Cell Biol., 2000, 20, 273-285.
29. Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 2000, 406, 207-210.
30. Lopatina, NG; Poole, JC; Saldanha, SN; Hansen, NJ; Key, JS; Pita, MA; Andrews, LG; Tollefsbol, TO. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human terocarcinoma cells. Biochem. Biophys. Res. Commmun., 2003, 306, 650-659.
31. Forsyth, NR; Wright, WE; Shay, JW. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation, 2002, 69, 188-197.
32. Lee, SW; Fang, L; Igarashi, M; Ouchi, T; Lu, KP; Aaronson, SA. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA, 2000, 97, 8302-8305.
33. Ferbeyre, G; de Stanchina, E; Lin, AW; Querido, E; McCurrach, ME; Hannon, GJ; Lowe, SW. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell Biol., 2002, 22, 3497-3508.
34. Staveley, BE; Ruel, L; Jin, J; Stambolic, V; Mastronardi, FG; Heiltzer, P; Woodgett, JR; Manoukian, AS. Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol., 1998, 8, 599-602.
35. Vanfleteren, JR; Braeckman, HP. Mechanisms of life span determination in Caenorhabditis elegans. Neurobiol. Aging, 1999, 20, 487-502.
36. Kenyon, C. A conserved regulatory system for aging. Cell, 2001, 105, 165-168.
37. Lin, K; Libina, N; Kenyon, C. Regulation of Caenorhabiditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet., 2001, 28, 139-145.
38. Longo, VD; Finch, CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science, 2003, 299, 1342-1346.
39. Backman, S; Stambolic, V; Mak, T. PTEN function in mammalian cell size regulation. Curr. Opin. Neurobiol., 2002, 12, 516-522.
40. Yunis, EJ; Salazar, M. Genetics of lifespan in mice. Genetica, 1993, 91, 211-223.
41. Parker, JC; Whiteman MD; Richter CB. Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents. Infect Immun. 1978, 19, 123-30.
42. Dear, KB; Salazar, M; Watson, AL; Gelman, RS; Bronson, R; Yunis, EJ. Traits that influence longevity in mice: a second look. Genetics, 1992, 132, 229-39.
43. Gelman, R; Watson E; Yunis EJ; Williams RM. Genetics of survival in mice: subregions of the major histocompatibility complex. Genetics., 1990, 25, 167-174.
44. Gelman, R; Watson, A; Bronson, R; Yunis, EJ. Murine chromosomal regions correlated with longevity. Genetics, 1988, 118, 693-704.
45. Zijlmans, JM; Martens, UM; Poon, SS; Raap, AK; Tanke, HJ; Ward, RK; Lansdorp, PM. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Porc. Natl. Acad. Sci. USA, 1997, 94, 7423-7428.
46. de Haan, G; Gellman, R; Yunis, EJ; Van Zant, G. A putative gene causes variability in lifespan among genotypically identical mice. Nature Genet., 1998, 19, 114-116.
47. Rossi, DJ; Bryder, D; Zahn, JM; Ahlenius, H; Sonu, R; Wagers, AJ; Weissman, IL. Cell intrinsic alterations underlie hematopoietic stem cell aging. Porc. Natl. Acad. Sci. USA, 2005, 102, 9194-9199.
48. Bhowmick, NA; et al. Stromal fibroblasts in cancer initiation and progression. Nature, 2004, 432, 332-337.
49. Suda, T; Arai F; Hirao A. hematopoietic stem cells and their niche. Trends in Immunology, 2005, 26, 426-433.
50. Fuchs, E; et al. Socializing with the neighborgs: stem cells and their niche. Cell, 2004, 116, 769-778.
51. Reya, T; Morrison SJ; Clarke MF; Weissman IL. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
52. Loeffler, M; Birke A; Winton D; Potten C. Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J. Theor. Biol., 1993, 160, 471-491.
53. Doetsch, F; Caille I; Lim DA; Garcia-Verdugo JM; Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999, 97, 703-716.
54. Duncan, AW; Rattis FM; DiMascio LN; Congdon KL; Pazianos G; Zhao C; Yoon K; Cook JM; Willert K; Gaiano N; Reya T. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol., 2005, 6, 314-22.
55. Welle, S; Brooks AI; Delehanty JM; Needler N; Thornton CA. Gene expression profile of aging in human muscle. Physiol Genomics., 2003, 14, 149-59.
56. Hamatani, T; Falco G; Carter MG; Akutsu H; Stagg CA; Sharov AA; Dudekula DB; VanBuren V; Ko MS. Age-associated alteration of gene expression patterns in mouse oocytes. Hum. Mol. Genet., 2004, 13, 2263-78.
57. Pansarasa, O; Bertorelli L; Vecchiet J; Felzani G; Marzatico F. Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. Free Radic Biol Med., 1999, 27, 617-622.
58. cip1/waf1. Science, 2000, 287, 1804-1808.
59. Wilson, A; Murphy MJ; Oskarsson T; Kaloulis K; Bettess MD; Oser GM; Pasche AC; Knabenhans C; Macdonald HR; Trumpp A. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004, 8, 2747-63.
60. Spangrude, GJ; Heimfeld S; Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science, 1988, 241, 58-62.
61. Okada, S; Nakauchi H; Nagayoshi K; Nishikawa S; Nishikawa S; Miura Y; Suda T. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood, 1991, 78, 1706-1712.
62. Akashi, K; Traver D; Miyamoto T; Weissman IL. A cologenic common myeloid progenitor that give rise to all myeloid lineages. Nature, 2000, 404, 193-197.
63. Greenwood, MJ; Lansdoep, PM. Telomeres, telomerase, and hematopoietic stem cell biology. Arch. Med. Res., 2003, 34, 489-495.
64. Ito, K; Hirao A; Arai F; Matsuoka S; Takubo K; Hamaguchi I; Nomiyama K; Hosokawa K; Sakurada K; Nakagata N; Ikeda Y; Mak TW; Suda T. Regulation of oxidative stress by ATM is required for self-renewal of hematopoietic stem cells. Nature, 2004, 431, 997-1002.
65. Henckaerts, E; Langer JC; Snoeck HW. Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice. Blood,. 2004, 104, 374-379.
66. Fabris N. Hormones and Aging. In, Comprehensive Immunology. Ed Rober A. Good and Stacey B. Day. Plenum Publishing Corporation, NY, 1977, p 72-89.
67. Montecino-Rodriquez, E; Min, H; Dorshkind, K. Reevaluating current models of thymic involution. Semin Immunol., 2005,17(5), 356-61.
68. Taub, DD; Longo, DL. Insights into thymic aging and regeneration. Immunol Rev., 2005, 205, 72-93.
69. Shen, MM; Skoda, RC; Cardiff, RD; Campos-Torres, J; Leder, P; Ornitz, DM. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J., 1994, 13, 1375-1385.
70. Hannestad, J; Monjil, DF; Diaz-Esnal, B; Cobo, J;, Vega, JA. Age-dependent changes in the nervous and endocrine control of the thymus. Microsc. Res. Tech., 2003, 63, 94-101.
71. Han, E; Hilsenbeck, SG; Richardson, A; Nelson, JF. cDNA expression arrays reveal incomplete reversal of age-related changes in gene expression by calorie restriction. Mech. Ageing. Dev., 2000, 115, 157-174.
72. Butler, RN; et al. Biomarkers of aging: from primitive organisms to humans. J. Gerontol. Biol. Sci. Med. Sci., 2004, 59, B560-B567.
73. Martin, MA; Bhatia, M. Analysis of the human fetal liver hematopoietic microenvironment. Stem Cells Dev., 2005, 14, 493-504.
74. LaFever, L; Drummond-Barbosa, D. Direct control of germline stem cell division and cyst growth by neural insulin in Drosophila. Science, 2005, 309, 1071-3.
75. Shi, S; Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res., 2003, 18, 696-704.
76. Yamashita, YM; Fuller MT; Jones DL. Signaling in stem cell niches: lessons from the Drosophila germline. J. Cell Sci., 2005, 118, 665-672.
77. Ma, DK; Ming, GL; Song, H. Glial influences on neural stem cell development: cellular niches for adult neurogenesis. Curr. Opin. Neurobiol., 2005, 15, 514-520.
78. Haylock, DN; Nilsson, DK. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle, 2005 (In press).
79. Heissig, B; Ohki, Y; Sato, Y; Rafii, S; Werb, Z; Hattori, K. A role for niches in hematopoietic cell development. Hematology, 2005, 10, 247-253.
80. Suzuki, T; Chiba, S. Notch signaling in hematopoietic stem cells. Int. J. Hematol., 2005, 82, 285-294.
81. Doetsch, F. A niche for adult neural stem cells. Curr. Opin. Genet. Dev., 2003, 13, 543-550.
82. Nilsson, SK Simmons, PJ. Transplantable stem cells: home to specific niches. Curr. Opin. Hematol., 2004, 11, 102-106.
83. Schaerli, P; Willimann, K; Ebert, LM; Walz, A; Moser, B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans Cell differentiation. Immunity, 2005, 23, 331-342.
84. Starnbach, MN; Bevan, MJ. Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J. Immunol., 1994, 153, 1603-1612.
85. Buckner, FS; Wipke, BT; Van Voorhis, WC. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Eur. J. Immunol., 1997, 27, 2541-2548.
86. Liu, Z; Savoldo, B; Huls, H; Lopez, T; Gee, A; Wilson, J; Brenner, MK; Heslop, HE; Rooney, CM. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas. Recent Results Cancer Res., 2002, 159, 123-133.
87. San Mateo, LR; Chua, MM; Weiss, SR; Shen, H. Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J. Immunol., 2002, 169, 5202-5208.
88. Choi, Y; Borghesani, PR; Chan, JA; Segal, RA. Migration from a mitogenic niche promotes cell-cycle exit. J. Neurosci., 2005, 25, 10437-10445.
89. Conti, L; Pollard, SM; Gorba, T; Reitano, E; Toselli, M; Biella, G; Sun, Y; Sanzone, S; Ying, QL; Cattaneo, E; Smith, A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol., 2005, 3, e283.
90. Garcion, E; Halilagic, A; Faissner, A; French-Constant, C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development, 2004, 131, 3423-3432.
91. Stier, S; Ko, Y; Forkert, R; Lutz, C; Neuhaus, T; Grunewald, E; Cheng, T; Dombkowski, D; Calvi, LM; Rittling, SR; Scadden, DT. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med., 2005, 201, 1781-1791.
92. Nilsson, SK; Johnston, HM; Whitty, GA; Williams, B; Webb, RJ; Denhardt, DT; Bertoncello, I; Bendall, LJ; Simmons, PJ; Haylock, DN. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 2005, 106, 1232-1239.
93. Hirao, A; Arai, F; Suda, T. Regulation of cell cycle in hemetopoietic stem cells by the niche. Cell Cycle, 2004, 3, 1481-1483.
94. Moore, KA; Limischka IR. "Tie-ing" down the hematopoietic niche. Cell, 2004, 118, 149-161.
95. Moore, KA. Recent advances in defining the hematopoietic stem cell niche. Curr. Opin. Hematol., 2004, 11, 107-111.
96. Rattis, FM; Voermans, C; Reya, T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol., 2004, 11, 88-94.
97. Shen, Q; Goderie, SK; Jin, L; Karanth, N; Sun, Y; Abramova, N; Vincent, P; Pumiglia, K; Temple, S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science, 2004, 304, 1253-1255.
98. Hackney, JA; Charbord, P; Brunk, BP; Stoeckert, CJ; Lemischka, IR; Moore, KA. A molecular profile of a hematopoietic stem cell niche. Proc. Natl. Acad. Sci. USA., 2002, 99, 13061-13066.
99. Nolta, JA; Thiemann, FT; Arakawa-Hoyt, J; Dao, MA; Barsky, LW; Moore, KA; Lemischka, IR; Crooks, GM. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors. Leukemia 2002, 16, 352-361.
100. Koka, PS; Reddy, ST. Cytopenias in HIV infection: Mechanisms and alleviation of hematopoietic inhibition. Curr. HIV Res., 2004, 2, 275-282.
101. Miles, SA; Mitsuyasu, RT; Moreno, J; Baldwin, G; Alton, NK; Souza, L; Glaspy, JA. Combined therapy with recombinant granulocyte colony-stimulating factor and etythropoietin decreases hematologic toxicity from zidovudine. Blood, 1991, 77, 2109-2117.
102. Miles, SA; Lee, S; Hutlin, L; Zsebo, KM; Mitsuyasu, RT. Potential use of Human stem cell factor as adjunctive therapy for Human immunodeficiency virus-related cytopenias. Blood, 1991, 78, 3200-3208.
103. Ratner, L. Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: A review. Am. J. Med., 1989, 86, 194-198.
104. Fauci, AS. Host factors and the pathogenesis of HIV-induced disease. Nature, 1996, 384, 529-534.
105. Harbol, AW; Liesveld, JL; Simpson-Haidaris, PJ; Abboud, CN. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev., 1994, 8, 241-251.
106. Shen, H; Cheng, T; Preffer, FI; Dombkowski, D; Tomasson, MH; Golan, DE; Yang, O; Hofmann, W; Sodroski, JG; Luster, AD; Scadden, DT. Intrinsic Human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol., 1999, 73, 728-737.
107. Koka, PS; Jamieson, BD; Brooks, DG; Zack, JA. Human immunodeficiency virus type-1 induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J. Virol. 1999, 73, 9089-9097.
108. Koka, PS; Fraser, JK; Bryson, Y; Bristol, GC; Aldrovandi, GM; Daar, ES; Zack, JA. Human immunodeficiency virus type 1 inhibits multilineage hematopoiesis in vivo. J. Virol., 1998, 72, 5121-5127.
109. Jenkins, M; Hanley, MB; Moreno, MB; Wieder, E; McCune, JM. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood, 1998, 91, 2672-2678.
110. Koka, PS; Kitchen, CM; Reddy, ST. Targeting c-Mp1 for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34± progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo. J. Virol., 2004, 78, 11385-11392.
111. Lee, JS; Campbell, HD; Kozak, CA; Young, IG. The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome 11. Somat. Cell Mol. Genet., 1989, 15, 143-152.
112. D'Eustachio, P; Brown, M; Watson, C; Paul, WE. The IL-4 gene maps to chromosome 11, near the gene encoding IL-3. J. Immunol., 1988, 141, 3067-3071.
113. Barlow, DP; Bucan, M; Lehrach, H; Hogan, BL; Gough, NM. Close genetic and physical linkage between the murine haemopoietic growth factor genes GM-CSF and Multi-CSF (IL3). EMBO J., 1987, 6, 617-623.
114. Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA. Interchromosomal associations between alternatively expressed loci. Nature, 2005, 435, 637-645.
115. Altomare, DA; Guo, K; Cheng, JQ; Sonoda, G; Walsh, K; Testa JR. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene, 1995, 11, 1055-1060.
116. Mock, BA; Givol, D; D'Hoostelaere, LA; Huppi, K; Seldin, MF; Gurfinkel, N; Unger, T; Potter, M; Mushinski, JF. Mapping of the bcl-2 oncogene on mouse chromosome 1. Cytogenet Cell Genet., 1988, 47, 11-15.
117. Murthy, SS; Tosolini, A; Taguchi, T; Testa, JR. Mapping of AKT3, encoding a member of the Akt/protein kinase B family, to human and rodent chromosomes by fluorescence in situ hybridization. Cytogenet. Cell. Genet., 2000, 88, 38-40.
118. Haupt, Y; Barri, G; Adams JM. Nucleotide sequence of bup, an upstream gene in the bmi-1 proviral insertion locus. Mol. Biol. Rep., 1992, 17, 17-20.
119. Pecker, I; Avraham, KB; Gilbert, DJ; Savitsky, K; Rotman, G; Harnik, R; Fukao, T; Schrock, E; Hirotsune, S; Tagle, DA; Collins, FS; Wynshaw-Boris, A; Ried, T; Copeland, NG; Jenkins, NA; Shiloh, Y; Ziv, Y. Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia gene. Genomics, 1996, 35, 39-45.
120. Justice, MJ; Siracusa, LD; Gilbert, DJ; Heisterkamp, N; Groffen, J; Chada, K; Silan, CM;. Copeland, NG; Jenkins, NA. A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross. Genetics, 1990, 125, 855-866.
121. Avraham, S; Jiang, S; Ota, S; Fu, Y; Deng, B; Dowler, LL; White, RA; Avraham, H. Structural and functional studies of the intracellular tyrosine kinase MATK gene and its translated product. J. Biol. Chem., 1995, 270, 1833-1842.
122. Czosnek, HH; Bienz, B; Givol, D; Zakut-Houri, R; Pravtcheva, DD; Ruddle, FH; Oren, M. The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes. Mol. Cell. Biol, 1984, 4, 1638-1640.
123. Rotter, V; Wolf, D; Pravtcheva, D; Ruddle, FH. Chromosomal assignment of the murine gene encoding the transformation-related protein p53. Mol. Cell. Biol., 1984, 4, 383-385.
124. Cho, M; Villain, V; D'Eustachio, P. A linkage map of distal mouse chromosome 12. Mamm Genome, 1991, 1, 30-36.
125. Stone, JC; Crosby, JL; Kozak, CA; Schievella, AR; Bernards, R; Nadeau, JH. The munine retinoblastoma homolog maps to chromosome 14 near Es-10. Genomics, 1989, 5, 70-75.
126. Banerjee, M; Wiener, F; Spira, J; Babonits, M; Nilsson, MG; Sumegi, J; Klein, G. Mapping of the c-myc, pvt-1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma-associated variant (6; 15) translocation breakpoint., EMBO J., 1985, 4, 3183-3188.
127. Huppi, K; Siwarski, D; Dosik, J; Michieli, P; Chedid, M; Reed, S; Mock, B; Givol, D; Mushinski, JF. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene, 1994, 9, 3017-3020.
128. Kojima, T; Yoshikawa, Y; Takada, S; Sato, M; Nakamura, T; Takahashi, N; Copeland, NG; Gilbert, DI; Jenkins, NA; Mori N. Genomic organization of the Shc-related phosphotyrosine adapters and characterization of the full-length Sck/ShcB: specific association of p68-Sck/ShcB with pp135. Biochem. Biophys. Res. Commun., 2001, 284, 1039-1047.
129. Webb, GC; Campbell, HD; Lee, JS; Young, IG. Mapping the gene for murine T-cell growth factor, Il-2, to bands B-C on chromosome 3 and for the alpha chain of the IL-2-receptor, Il-2ra, to bands A2-A3 on chromosome 2. Cytogenet. Cell. Genet., 1990, 54, 164-168.
130. Nelson, KK; Knopf, JL; Siracusa, LD. Localization of phospholipase C-gamma 1 to mouse chromosome 2. Mamm Genome., 1992, 3, 597-600.
131. Vidal, M. Interactome modeling. FEBS Lett., 2005, 579, 1834-1838.
132. Rual, JF; et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature, 2005, 437, 1173-1178.
133. Fernandes, G; Good, RA; Yunis, EJ. Responses of autoimmune diseases and diseases of aging to dietary restriction, in: Immunological Aspects of Aging. D. Segre and L. Smith, eds., Marcel Dekker, Inc., New York 1981; p. 207.
134. Anderson, DJ; Watson, ALM; Yunis, EJ. Environmental and genetic factors that influence immunity and longevity in mice. Mol. Biol. Aging, 1985, 1, 231-240.
135. Dubey, DP; Husain, Z; Levitan, E; Zurakowski, D; Mirza, N; Younes, S; Cononell, C; Yunis, D; Yunis, EJ. The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan. Mech. Ageing Dev., 2000, 113, 117-134.
136. Strelkauskas, AJ; Andrews, JA; Yunis, EJ. Autoantibodies to a regulatory T cell subset in human ageing. Clin. Exp. Immunol., 1981, 45, 308-315.
137. Caruso, C; Candore, G; Colonna-Romano, G; Lio, D; Bonafe, M; Valensin, S; Franceschi, C. HLA, aging and longevity a critical reappraisal. Human Immunol., 2000, 61, 942-949.
138. Wilson, AG; Gordon, C; di Giovine, FS; de Vries, N; van de Putte, LB; Emery, P; Duff, GW. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur. J. Immunol., 1994, 24, 191-195.
139. Waldron-Lynch, F; Adams, C; Amos, C; Zhu, DK; McDermott, MF; Shanahan, F; Molloy, MG; O'Gara, F. Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun., 2001, 2, 82-87.
140. Rodriguez-Carreon, AA; Zuniga, J; Hernandez-Pacheco, G; Rodriguez-Perez, JM; Perez-Hernandez, N; Montes de Oca, JV; Cardiel, MH; Granados, J; Vargas-Alarcon, G. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J. Autoimmun., 2005, 24, 63-68.
141. Molokhia, M; McKeigue, P. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res., 2000, 2, 115-125.
142. Cipriano, C; Caruso, C; Lio, D; Giacconi, R; Malavolta, M; Muti, E; Gasparini, N; Franceschi, C; Mocchegiani, E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet., 2005, 32, 13-18.
143. Ross, OA; Curran, MD; Rea, LM; Hyland, P; Duggan, O; Barnett, CR; Annett, K; Patterson, C; Barnett, YA; Middleton, D. HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev., 2003, 124, 563-567.
144. Yunis, EJ; Larsen, CE; Fernandez-Vina, M; Awdeh, ZL; Romero, T; Hansen, JA; Alper, CA. Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens, 2003, 62, 1-20.
145. Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW. Genetic structure of human populations. Science, 2002, 298, 2381-2385.
146. Akisaka, M; Suzuki, M; Inoko, H. Molecular genetic studies on DNA polymorphism of the HLA class II genes associated with human longevity. Tissue Antigens, 1997, 50, 489-493.
147. Papasteriades, C; Boki, K; Pappa, H; Aedonopoulos, S; Papasteriadis, E; Economidou, J. HLA phenotypes in healthy aged subjects. Gerontology, 1997, 43, 176-181.
148. Lio, D; Pes, GM; Carru, C; Listi, F; Ferlazzo, V; Candore, G; Colonna-Romano, G; Ferrucci, L; Deiana, L; Baggio, G; Franceschi, C; Caruso, C. Association between the HLA-DR alleles and longevity: a study in Sardinian population. Exp. Gerontol., 2003, 38, 313-317.
149. Purdom, S; Chen, QM. p66(Shc): at the crossroad of oxidative stress and the genetics of aging. Trends Mol. Med., 2003, 9, 206-210.
150. Dangond, F; Gullans, SR. Differential expression of human histone deacetylase mRNA in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem. Biophys. Res. Commun., 1998, 242, 648-652.
151. McClearn, GE. Prospects for quantitative trait locus methodology in gerontology. Exp. Gerontol., 1997, 32, 49-54.
152. Fernandez, G; Good, RA; Yunis EJ. Attempts to correct age-related immunodeficiency and autoimmunity by cellular and dietary manipulation in inbred mice. Immunology and Aging, edited by T. Makinodan and EJ Yunis, New York Plenum. 1977, 111-133.
153. Holliday, R. DNA methylation and epigenotypes. Biochemistry, 2005, 70, 500-504.
154. Greenberg, LJ; Yunis, EJ. Histocompatibility determinants, immune responsiveness and aging in man. Fed. Proc., 1978, 37, 1258-1262.
155. Rea, IM; Middleton, D. Is the phenotypic combination AIB8Cw7DR3 a marker for male longevity? J. Am. Geriatr. Soc., 1994, 42, 978-983.
156. Ivanova, R; Hénon, N; Lepage, V; Charron, D; Vicaut, E; Schächter, F. HLA-DR alleles display sex-dependent effects on survival discriminate between individual and familial longevity. Human Mol. Genet., 1998, 7, 187-194.
157. Ricci, G; Colombo, C; Ghiazza, B; Illeni, MT. Association between longevity and allelic forms of human leukocyte antigens (HLA): population study of aged Italian human subjects. Arch. Immunol. Ther. Exp. (Warsz), 1998, 46, 31-34.
158. Singh, R; Kolvraa, S; Bross, P; Gregersen, N; Andersen Nexo, B; Frederiksen, H; Christensen, K; Rattan, SI. Association between low self-rated health and heterozygosity for -110A > C polymorphism in the promoter region of HSP70-1 in aged Danish twins. Biogerontology, 2004, 5, 169-176.
159. Pes, GM; Lio, D; Carru, C; Deiana, L; Baggio, G; Franceschi, C; Ferrucci, L; Oliveri, F; Scola, L; Crivello, A; Candore, G; Colonna-Romano, G; Caruso, C. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin. Exp. Res., 2004, 16, 244-248.
160. Christiansen, L; Bathum, L; Andersen-Ranberg, K; Jeune, B; Christensen, K. Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech. Ageing Dev., 2004, 125, 391-395.
161. Naumova, E; Mihaylova, E; Ivanova, M; Michailova, S; Penkova, K; Baltadjieva, D. Immunological markers contributing to successful aging in Bulgarians. Exp. Gerontol., 2004, 39, 637-644.
162. Lio, D; Scola, L; Crivello, A; Colonna-Romano, G; Candore, G; Bonafe, M; Cavallone, L; Marchegiani, F; Olivieri, F; Franceschi, C; Caruso, C. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J. Med. Genet., 2003, 40, 296-299.
163. Carrieri, G; Marzi, E; Olivieri, F; Marchegiani, F; Cavallone, L; Cardelli, M; Giovagnetti, S; Stecconi, R; Molendini, C; Trapassi, C; De Benedictis, G; Kletsas, D; Franceschi, C. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell., 2004, 3, 443-448.